Dergiler / Journal of Pharmaceutical Technology
Journal of Pharmaceutical Technology
Journal of Pharmaceutical Technology “ JPharmTech ” is an online peer-reviewed journal following the guidelines provided by the International Committee of Medical Journal Editors (ICMJE) and Committee on Publication Ethics (COPE) . All published articles in the JPharmTech will be assigned with a unique Digital Objective Identifier (DOI) provided by CrossRef and archived by the LOCKSS system, which guarantees long-term digital preservation of the paper. JPharmTech is an open-access journal. It provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. The manuscripts submitted to the JPharmTech are double-blind peer-reviewed. Submitted manuscripts must not have been previously published elsewhere and not currently be under review by another journal. Processing and publication are free of charge. JPharmTech publishes two issues per year (June and December) and accepts research articles and review articles on all aspects of pharmaceutical technology. Corresponding authors should submit their manuscripts through the online submission system of Dergipark .
Aşağıdaki metinler katalog kaydındaki yayıncı beyanıdır. AJIndex bunları yeniden doğrulamamıştır. Gönderim sistemi AJIndex üzerinde değildir.
Amaç
Amaç ve Kapsam JPharmTech aims to inform all pharmaceutical scientists about the latest and essential research on drug development. JPharmTech ’s primary and future goals are; to have a strong international editorial and advisory board to increase the recognition of the JPharmTech world-wide to be one of the most-cited journals with a high impact factor JPharmTech publishes two issues per year (June, and December) and primarily accepts original research and review articles covering the formulation, characterization and stability studies of drug delivery systems as well as the latest studies and scientific findings on the products already marketed. JPharmTech accepts manuscripts from the following areas: Conventional drug delivery systems Novel drug delivery systems Biopharmaceutics Pharmacokinetics Bioavailability & bioequivalence Radiopharmaceuticals Pharmaceutical technology Pharmaceutical nano & biotechnology Cosmetics & cosmeceutical products Nutraceuticals Quality control of dosage forms Yayımlanma Ayları Haziran Aralık
Kapsam
Journal of Pharmaceutical Technology “ JPharmTech ” is an online peer-reviewed journal following the guidelines provided by the International Committee of Medical Journal Editors (ICMJE) and Committee on Publication Ethics (COPE) . All published articles in the JPharmTech will be assigned with a unique Digital Objective Identifier (DOI) provided by CrossRef and archived by the LOCKSS system, which guarantees long-term digital preservation of the paper. JPharmTech is an open-access journal. It provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. The manuscripts submitted to the JPharmTech are double-blind peer-reviewed. Submitted manuscripts must not have been previously published elsewhere and not currently be under review by another journal. Processing and publication are free of charge. JPharmTech publishes two issues per year (June and December) and accepts research articles and review articles on all aspects of pharmaceutical technology. Corresponding authors should submit their manuscripts through the online submission system of Dergipark .
Yayın kurulu
Belirtilmemiş
İletişim
Belirtilmemiş
Yayın sıklığı
Belirtilmemiş
Gönderim bağlantısı
Belirtilmemiş. Derginin web sitesi